🚀 VC round data is live in beta, check it out!
Ottobock Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ottobock and similar public comparables like Renishaw, Medacta Group, Sectra, MGI Tech and more.
Ottobock Overview
About Ottobock
Ottobock SE & Co KGaA is a medical technology company. It specializes in products and services designed to improve mobility and quality of life for people with disabilities or limited mobility. The company's portfolio includes prosthetics, orthotics, neuro-orthotics, rehabilitation products, wheelchairs, and bionic exoskeletons. Ottobock operates a network of patient care centers and service locations in various countries, providing tailored solutions and support to users. The company’s geographical segments include Europe, the Middle East and Africa (EMEA), the Americas, and Asia Pacific (APAC), generating the majority of revenue from the EMEA segment.
Founded
1999
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$5B
Ottobock Financials
Ottobock reported last 12-month revenue of $2B and EBITDA of $473M.
In the same LTM period, Ottobock generated $473M in EBITDA and $152M in net income.
Revenue (LTM)
Ottobock P&L
In the most recent fiscal year, Ottobock reported revenue of $2B and EBITDA of $341M.
Ottobock expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $936M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 51% | XXX | XXX | XXX |
| EBITDA | $473M | XXX | $341M | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $152M | XXX | $35M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | — | — | $1B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Ottobock Stock Performance
Ottobock has current market cap of $4B, and enterprise value of $5B.
Market Cap Evolution
Ottobock's stock price is $65.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $4B | — | XXX | XXX | XXX | $0.54 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOttobock Valuation Multiples
Ottobock trades at 2.8x EV/Revenue multiple, and 11.5x EV/EBITDA.
EV / Revenue (LTM)
Ottobock Financial Valuation Multiples
As of March 28, 2026, Ottobock has market cap of $4B and EV of $5B.
Equity research analysts estimate Ottobock's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ottobock has a P/E ratio of 27.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 2.8x | XXX | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | 11.5x | XXX | 15.9x | XXX | XXX | XXX |
| EV/EBIT | 18.1x | XXX | 28.9x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.8x | XXX | XXX | XXX |
| P/E | 27.3x | XXX | 119.4x | XXX | XXX | XXX |
| EV/FCF | 24.9x | XXX | 27.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ottobock Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Ottobock Margins & Growth Rates
Ottobock's revenue in the last 12 month grew by 6%.
Ottobock's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ottobock's rule of X is 39% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Ottobock Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 34% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 30% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 39% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 22% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 13% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Ottobock Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Renishaw | XXX | XXX | XXX | XXX | XXX | XXX |
| Medacta Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Sectra | XXX | XXX | XXX | XXX | XXX | XXX |
| MGI Tech | XXX | XXX | XXX | XXX | XXX | XXX |
| LivaNova | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ottobock M&A Activity
Ottobock acquired XXX companies to date.
Last acquisition by Ottobock was on XXXXXXXX, XXXXX. Ottobock acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Ottobock
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOttobock Investment Activity
Ottobock invested in XXX companies to date.
Ottobock made its latest investment on XXXXXXXX, XXXXX. Ottobock invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Ottobock
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ottobock
| When was Ottobock founded? | Ottobock was founded in 1999. |
| Where is Ottobock headquartered? | Ottobock is headquartered in Germany. |
| Is Ottobock publicly listed? | Yes, Ottobock is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Ottobock? | Ottobock trades under OBCK ticker. |
| When did Ottobock go public? | Ottobock went public in 2025. |
| Who are competitors of Ottobock? | Ottobock main competitors are Renishaw, Medacta Group, Sectra, MGI Tech. |
| What is the current market cap of Ottobock? | Ottobock's current market cap is $4B. |
| What is the current revenue of Ottobock? | Ottobock's last 12 months revenue is $2B. |
| What is the current revenue growth of Ottobock? | Ottobock revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Ottobock? | Current revenue multiple of Ottobock is 2.8x. |
| Is Ottobock profitable? | Yes, Ottobock is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ottobock? | Ottobock's last 12 months EBITDA is $473M. |
| What is Ottobock's EBITDA margin? | Ottobock's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Ottobock? | Current EBITDA multiple of Ottobock is 11.5x. |
| What is the current FCF of Ottobock? | Ottobock's last 12 months FCF is $218M. |
| What is Ottobock's FCF margin? | Ottobock's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Ottobock? | Current FCF multiple of Ottobock is 24.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.